Mitomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 68083-484

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Mitomycin (NDC 68083-484). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-label-20mg (Mitomycin Spl Carton Label 20mg)

Packaging label for Mitomycin for Injection, USP, 20 mg/vial in lyophilized powder form for intravenous use. Label displays product name, strength, single-dose vial indication, Rx only status, warnings about intravenous administration to avoid tissue damage, and cytotoxic agent caution. Manufacturer is Gland Pharma Limited, with barcode and storage instructions included on the label.*

FDA Label Image

Carton-label-5mg (Mitomycin Spl Carton Label 5mg)

Packaging label for Mitomycin for Injection, USP, 5 mg/vial, a lyophilized powder for solution intended for intravenous use. The label shows the brand and generic name, dosage strength, warnings about intravenous administration, cytotoxic caution, and storage instructions. It also includes manufacturer details for Gland Pharma Limited, a barcode, and regulatory information. This is a single-dose vial label.*

FDA Label Image

Container-label-20mg (Mitomycin Spl Container Label 20mg)

Label for Mitomycin Injection, USP, 20 mg per vial, lyophilized powder for intravenous solution. The label includes NDC 68083-484-01 and lists contents as 20 mg mitomycin with 40 mg mannitol. Instructions for storage, reconstitution, and warnings about intravenous use and cytotoxicity are displayed. Manufactured by Gland Pharma Limited, India.*

FDA Label Image

Container-label-20mg (Mitomycin Spl Container Label 5mg)

Label for Mitomycin for Injection, USP 5 mg/vial by Gland Pharma Limited. This single-dose vial contains mitomycin 5 mg and mannitol 10 mg as powder for intravenous injection after reconstitution. The label includes dosage instructions, storage conditions, and caution regarding cytotoxicity, emphasizing avoidance of tissue damage.*

FDA Label Image

Mitomycin-spl-structure (Mitomycin Spl Structure)

Chemical structure of Mitomycin, showing the molecular arrangement of atoms and bonds characteristic of the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.